Vasamed, Inc.
VSMD · OTC
12/31/2005 | 12/31/2004 | 12/31/2003 | 12/31/2002 | |
|---|---|---|---|---|
| Market Cap | $7,435 | $10,417 | $13,089 | $10,987 |
| - Cash | $1 | $9 | $17 | $244 |
| + Debt | $23 | $0 | $0 | $0 |
| Enterprise Value | $7,457 | $10,408 | $13,072 | $10,743 |
| Revenue | $1,386 | $1,069 | $2,124 | $1,575 |
| % Growth | 29.7% | -49.7% | 34.9% | – |
| Gross Profit | -$69 | -$318 | $316 | $1,153 |
| % Margin | -5% | -29.8% | 14.9% | 73.2% |
| EBITDA | -$4,574 | -$6,074 | -$2,196 | -$1,738 |
| % Margin | -330% | -568.1% | -103.4% | -110.3% |
| Net Income | -$4,888 | -$6,422 | -$2,281 | -$1,853 |
| % Margin | -352.6% | -600.7% | -107.4% | -117.6% |
| EPS Diluted | -1.31 | -1.85 | -0.71 | -0.67 |
| % Growth | 29.2% | -160.6% | -6% | – |
| Operating Cash Flow | -$4,667 | -$3,953 | -$1,639 | -$2,236 |
| Capital Expenditures | -$244 | -$88 | -$107 | -$183 |
| Free Cash Flow | -$4,911 | -$4,042 | -$1,746 | -$2,419 |